Business Context and Reporting Period
This Form 8-K is filed by Anthem, Inc. (now Elevance Health, Inc.) for the reporting date of December 17, 2001. The filing serves as a Regulation FD disclosure regarding upcoming meetings between company officers and securities analysts/investors scheduled for the week of December 17, 2001.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release and conference call from November 14, 2001, which contained earnings expectations, but does not reproduce those specific financial figures within this document.
Material Changes
No material changes to financial results or operations are reported in this specific filing. The document confirms that officers intend to reiterate earnings expectations previously communicated on November 14, 2001.
Guidance, Outlook, and Risks
Management expects to confirm prior earnings guidance during analyst meetings. The filing explicitly identifies the following risks and uncertainties that could cause actual results to differ from forward-looking statements:
- Trends in health care costs and utilization rates.
- Ability to secure sufficient premium rate increases.
- Competitor pricing below market trends of increasing costs.
- Increased government regulation of health benefits and managed care.
- Significant acquisitions or divestitures by major competitors.
- Introduction and utilization of new prescription drugs and technology.
- Potential downgrade in financial strength ratings.
- Litigation targeted at health benefits companies.
- Ability to contract with providers consistent with past practice.
- General economic downturns.
The company disclaims any obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the specific earnings expectations detailed in the November 14, 2001 press release (filed as Exhibit 99 to the prior 8-K).
- Review the final Prospectus dated October 29, 2001, for the initial public offering.
- Examine periodic reports (Form 10-K, 10-Q, and 8-K) for detailed financial data and risk factors.
- Monitor the company's financial strength ratings and regulatory environment changes.